Characteristics of patients receiving ustekinumab compared with secukinumab for treatment of moderate‐to‐severe plaque psoriasis – nationwide results from the DERMBIO registry

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles